The pharmaceutical world is observing a remarkable shift in glucose management with the emergence of GLP-1 patches. These devices offer a possibly more user-friendly alternative to subcutaneous administrations of GLP-1 drugs, minimizing the need for daily needle sticks. The technology releases the medication directly through the surface, possibly i